40 related articles for article (PubMed ID: 35260040)
1. Can MRI Accurately Diagnose and Stage Endometrial Adenocarcinoma?
Rizescu RA; Sălcianu IA; Șerbănoiu A; Ion RT; Florescu LM; Gheonea IA; Iana G; Bratu AM
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541238
[No Abstract] [Full Text] [Related]
2. Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study.
Sulaiman R; Dale A; Lin X; Aske JC; Gaster K; Starks D; Espaillat LR; De P; Dey N
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542414
[TBL] [Abstract][Full Text] [Related]
3. Effect of coexisting adenomyosis on tumour characteristics and prognosis of endometrial cancer: A systematic review and meta-analysis.
Wang DG; Ji LM; Jia CL; Shao MJ
Taiwan J Obstet Gynecol; 2023 Sep; 62(5):640-650. PubMed ID: 37678989
[TBL] [Abstract][Full Text] [Related]
4. Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)? A systematic review and meta-analysis.
Sun Y; Lin S; Wu W; Nie F; Liu Y; Wen J; Cheng X; Liu Q; Wang Y; Ren F
Int J Surg; 2024 May; 110(5):3072-3080. PubMed ID: 38445439
[TBL] [Abstract][Full Text] [Related]
5. Endometrioid adenocarcinoma caused by adenomyosis: A case report.
Chen YH; Zhou Y; Xue M; Sun L
Asian J Surg; 2024 Apr; 47(4):1921-1922. PubMed ID: 38262788
[No Abstract] [Full Text] [Related]
6. The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer.
Jiang P; Tian C; Zheng Y; Gong C; Wang J; Liu Y
Front Oncol; 2024; 14():1338908. PubMed ID: 38706601
[TBL] [Abstract][Full Text] [Related]
7. Molecular Signature of Endometrial Cancer with Coexistent Adenomyosis: A Multicentric Exploratory Analysis.
Raimondo D; Raffone A; Virgilio A; Ferla S; Maletta M; Neola D; Travaglino A; Paradisi R; Hernández A; Spagnolo E; García-Pineda V; Lenzi J; Guida M; Casadio P; Seracchioli R
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958382
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Intraluminal Tumor Cell Involvement in Serially Examined Fallopian Tubes and Endometrial Carcinoma Characteristics and Outcomes.
Rodriquez M; Felix AS; Brett MA; Samimi G; Duggan MA
Int J Gynecol Pathol; 2022 Sep; 41(5):520-529. PubMed ID: 34380972
[TBL] [Abstract][Full Text] [Related]
9. SLC38A2 promotes cell proliferation and invasion by promoting glutamine metabolism in adenomyosis.
Wu K; Gong W; Hu JC; Duan YC; Ke HH; Chen L
Exp Ther Med; 2024 May; 27(5):218. PubMed ID: 38590564
[TBL] [Abstract][Full Text] [Related]
10. Endometrial Carcinoma: A Comprehensive Analysis of Clinical Parameters, Treatment Modalities, and Prognostic Outcomes at a Tertiary Oncology Center in the UAE.
Balaraj KS; Shanbhag NM; Bin Sumaida A; Hasnain SM; El-Koha OA; Puratchipithan R; Al Kaabi KM; Dawoud EA; Nasim MY; Hassan TA; Roy S
Cureus; 2023 Nov; 15(11):e48689. PubMed ID: 38024019
[TBL] [Abstract][Full Text] [Related]
11. Endometrial cancer arising from adenomyosis with unusual manifestation: A case report.
Shahnazari R; Shirzadi S; Karaji S; Mokhles P; Far MJG; Maghsudlu S
Clin Case Rep; 2024 Jan; 12(1):e8353. PubMed ID: 38161634
[TBL] [Abstract][Full Text] [Related]
12. Letter to the editor: A commentary on 'Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)? a systematic review and meta-analysis'.
Sun Y; Ye L; Zhang C
Int J Surg; 2024 May; ():. PubMed ID: 38814368
[No Abstract] [Full Text] [Related]
13. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
14. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Adenomyosis in Myometrial Invasion and Overall Survival in Endometrial Cancer.
Erkilinç S; Taylan E; Gülseren V; Erkilinç G; Karadeniz T; Bağci M; Temel O; Solmaz U; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Jan; 28(1):145-151. PubMed ID: 29040186
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis.
An M; Duan H; Zhang Y
J Obstet Gynaecol Res; 2020 Sep; 46(9):1851-1863. PubMed ID: 32686169
[TBL] [Abstract][Full Text] [Related]
17. Impact of adenomyosis on the prognosis of patients with endometrial cancer.
Raimondo D; Raffone A; Travaglino A; Maletta M; Casadio P; Ambrosio M; Chiara Aru A; Santoro A; Franco Zannoni G; Insabato L; Mollo A; Zullo F; Seracchioli R
Int J Gynaecol Obstet; 2022 May; 157(2):265-270. PubMed ID: 34228822
[TBL] [Abstract][Full Text] [Related]
18. The impact of uterine adenomyosis on the histopathological risk factors and survival in patients with endometrial adenocarcinoma.
Yetimalar MH; Kilic D; Bezircioglu I; Yigit S
J Obstet Gynaecol; 2022 Aug; 42(6):2213-2219. PubMed ID: 35260040
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
